Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price dropped 2.3% on Wednesday . The company traded as low as $1.22 and last traded at $1.25. Approximately 707,885 shares changed hands during trading, an increase of 955% from the average daily volume of 67,097 shares. The stock had previously closed at $1.28.
Cardiol Therapeutics Price Performance
The business’s fifty day moving average is $1.68 and its two-hundred day moving average is $1.94.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- Trading Halts Explained
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 2 Drone Stocks Surging from Increased Media Attention
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
